Forum Private Client Group’s BioLife Solutions BLFS Stock Holding History

Forum Private Client Group’s Portfolio BLFS Stock Details BLFS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,585	Closed	-$208K	–	81
2025 Q4	$208K	Sell	8,585 -2,183	-20%	-$57.1K	0.07%	80
2025 Q3	$275K	Hold	10,768	–	–	0.1%	71
2025 Q2	$232K	Buy	+10,768	New	+$243K	0.09%	74
2024 Q4	–	Sell	-15,136	Closed	-$379K	–	76
2024 Q3	$379K	Buy	+15,136	New	+$357K	0.17%	53
2023 Q2	–	Sell	-9,872	Closed	-$215K	–	70
2023 Q1	$215K	Buy	+9,872	New	+$222K	0.14%	67
2022 Q4	–	Sell	-9,872	Closed	-$225K	–	67
2022 Q3	$225K	Buy	+9,872	New	+$211K	0.17%	60
2022 Q2	–	Sell	-9,872	Closed	-$224K	–	69
2022 Q1	$224K	Buy	+9,872	New	+$260K	0.17%	59

Other funds holding BLFS

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Forum Private Client Group's BLFS Position: Q1 2026 in Review

Forum Private Client Group sold out of BioLife Solutions (BLFS) in Q1 2026, closing a stake of 8,585 shares — an estimated $208K sold.

Forum Private Client Group first reported a position in BLFS in Q1 2022 and held it in 7 quarters. The position peaked at $379K in Q3 2024. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

Forum Private Client Group reported no remaining BioLife Solutions position as of Q1 2026 after selling out during the quarter.
Forum Private Client Group sold 8,585 BioLife Solutions shares in Q1 2026, an estimated $208K.
Forum Private Client Group first reported a position in BioLife Solutions in Q1 2022 and held it in 7 quarters.
Forum Private Client Group's BioLife Solutions position peaked at $379K in Q3 2024.
187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on Forum Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.